Alzheimer's drug lecanemab that slows decline given green light in UK - but won't be available on NHS - Sky News

[unable to retrieve full-text content]

1. Alzheimer's drug lecanemab that slows decline given green light in UK - but won't be available on NHS  Sky News
2. UK health regulator rejects lecanemab as treatment for Alzheimer’s  The Guardian
3. Lecanemab licensed for adult patients in the early stages of Alzheimer’s disease  GOV.UK
4. Benefits of new Alzheimer’s treatment lecanemab are too small to justify the cost to the NHS  NICE
5. Live news: Breakthrough Alzheimer’s drug approved in UK but too costly for NHS  Financial Times

https://news.google.com/rss/articles/CBMizgFBVV95cUxQYmtLaUl4Yzk3emVwTWtLZlVjS1drblptTGdfVjUtTXhDeEVodjBtQnVKMDczZ0ZDR1pIaDB0dUdCdEZyQldydXhTem5zcHRaMmZnZXR2a096VnBqQkc0WVpEcEVWN2dNb1lkNmNKbzlxSW0wcHlVTG9YSXpOekxKNHAtNG1pV1ZiQkpNV0h5NTBiUTYxT1lQVERxaVNaeUN4NnlCaExCU3RpTmJvUzJuUFpSV3h2aG50T0ZYSjRFbmJwVjdEblZ0b0NGU2Q0QQ?oc=5

2024-08-22 10:18:23Z
CBMizgFBVV95cUxQYmtLaUl4Yzk3emVwTWtLZlVjS1drblptTGdfVjUtTXhDeEVodjBtQnVKMDczZ0ZDR1pIaDB0dUdCdEZyQldydXhTem5zcHRaMmZnZXR2a096VnBqQkc0WVpEcEVWN2dNb1lkNmNKbzlxSW0wcHlVTG9YSXpOekxKNHAtNG1pV1ZiQkpNV0h5NTBiUTYxT1lQVERxaVNaeUN4NnlCaExCU3RpTmJvUzJuUFpSV3h2aG50T0ZYSjRFbmJwVjdEblZ0b0NGU2Q0QQ